SPAG11B (61-103) (Human) [7404]
SPAG11B (61-103) (Human)
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC1=O)[C@@H](C)CC |
| InChIKey | NZRXPCZWIFPFBB-SZWZVGMQSA-N |
| Sequence | DLLPPRTPPYQVHISHREARGPSFRICVDFLGPRWARGCSTGN |
| HELM | PEPTIDE1{D.L.L.P.P.R.T.P.P.Y.Q.V.H.I.S.H.R.E.A.R.G.P.S.F.R.I.C.V.D.F.L.G.P.R.W.A.R.G.C.S.T.G.N}$PEPTIDE1,PEPTIDE1,27:R3-39:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | 65 |
| Hydrogen bond donors | 64 |
| Rotatable bonds | 121 |
| Log P | -21.596 |
| Molecular weight (Da) | 4856.4 |
| Stereochemistry info | partial |
Database connections
No bioactivity data available.
SPAG11B (61-103) (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0